Episode Details

Back to Episodes
JAMA Oncology : Intracranial Outcomes in Melanoma Brain Metastases After Anti–PD-1 Therapy

JAMA Oncology : Intracranial Outcomes in Melanoma Brain Metastases After Anti–PD-1 Therapy

Published 1 year, 8 months ago
Description

Interview with Michael A. Postow, MD, author of Intracranial Outcomes of Ipilimumab and Nivolumab in Melanoma Brain Metastases After Progression on Anti–PD-1 Therapy. Hosted by Vivek Subbiah, MD.

Related Content:

Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us